OGEN Latest Press Releases

-- September 16, 2026 --

Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum Globe Newswire 8:30 AM

-- August 28, 2026 --

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update Globe Newswire 4:25 PM

-- July 7, 2026 --

Oragenics Achieves Full Activation of Australian Phase IIa Trial Network - All Three Sites Now Enrolling Globe Newswire 8:30 AM

-- May 19, 2026 --

Oragenics to Present at Sidoti's Micro-Cap Virtual Investor Conference May 20-21 Globe Newswire 8:45 AM

-- May 18, 2026 --

ORAGENICS PROVIDES INVESTOR UPDATE Globe Newswire 8:30 AM

-- May 7, 2026 --

Oragenics Signs Letter of Intent to License CardioDialysis Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation Globe Newswire 8:30 AM

-- May 5, 2026 --

Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury. Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software